Lung cancer
Conditions
Interventions
Experimental group:On the basis of standard treatment regimen, combined with BCG nebulization regimen
Sponsors
Shanghai public health clinical center
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Age >=18 years old, gender is not limited; 2. Pathological diagnosis of lung cancer; 3. Patients who have progressed clinically after receiving standard first-line and second-line treatment regimens; 4. Voluntarily participate in this clinical study and sign a written informed consent form by themselves or their legal guardians.
Exclusion criteria
Exclusion criteria: 1. Those suffering from tuberculosis, acute infectious diseases, nephritis, and heart disease 2. Those suffering from immunodeficiency; 3. Other situations that the investigator believes are not suitable for participating in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Security; | — |
Countries
China
Contacts
Public ContactHaicheng Tang
shanghai public health clinical center
Outcome results
None listed